Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic

Chunhong Yan1, Md S Jamaluddin, Bharat Aggarwal

  • 1Department of Cancer Biology, University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

Insights

Curcumin, a compound with known antitumor effects, was studied to find new molecular targets. Gene expression profiling identified activating transcription factor 3 (ATF3) as a key player in curcumin

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Curcumin (diferuloylmethane) exhibits established antitumor properties.
  • Unbiased studies to identify novel molecular targets of curcumin are lacking.
  • Understanding curcumin's molecular mechanisms is crucial for therapeutic development.

Purpose of the Study:

  • To identify novel molecular targets of curcumin using gene expression profiling.
  • To investigate the role of identified targets in curcumin's antitumor effects.
  • To elucidate the contribution of activating transcription factor 3 (ATF3) to curcumin-induced apoptosis.

Main Methods:

  • Gene expression profiling using a cDNA array with 12,625 probes.
  • Comparison of gene expression in curcumin-treated versus untreated MDA-1986 cells.
  • Quantitative analysis of mRNA and protein levels for key identified genes, including ATF3.

Main Results:

  • Identified 202 up-regulated and 505 down-regulated mRNAs (≥2-fold change).
  • Notable up-regulation of proapoptotic ATF3 (>4-fold), growth regulators (Mad, p27kip1), and phosphatases (CL 100, MKP-5).
  • Significant down-regulation of Frizzled-1 (8-fold), growth-related genes (K-sam, HER3), and E2F-5 transcription factor.

Conclusions:

  • Novel molecular targets of curcumin, including ATF3, have been identified.
  • Activating transcription factor 3 (ATF3) plays a significant role in mediating curcumin's proapoptotic effects.
  • Curcumin's antitumor activity involves modulation of multiple signaling pathways regulating apoptosis and cell growth.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...